Skip to Main Content

Paper Details

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine.
Oncoimmunology
8
2021
Author NameAffiliation
Samuel LeungUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2